Clinical Significance of Tumour-Infiltrating B Lymphocytes (TIL-Bs) in Breast Cancer: A Systematic Literature Review.
Lam BM. and Verrill C., (2023), Cancers (Basel), 15
Impact of the transition to digital pathology in a clinical setting on histopathologists in training: experiences and perceived challenges within a UK training region.
Browning L. et al, (2022), J Clin Pathol
A Graph Based Neural Network Approach to Immune Profiling of Multiplexed Tissue Samples.
Martin NG. et al, (2022), Annu Int Conf IEEE Eng Med Biol Soc, 2022, 3063 - 3067
The Use of Digital Pathology and Artificial Intelligence in Histopathological Diagnostic Assessment of Prostate Cancer: A Survey of Prostate Cancer UK Supporters.
Rakovic K. et al, (2022), Diagnostics (Basel), 12
Lessons from a breast cell annotation competition series for school pupils
Lu W. and VERRILL C., (2022), Scientific Reports
Automated Quality Assessment of Large Digitised Histology Cohorts by Artificial Intelligence
VERRILL C. et al, (2022), Scientific Reports
Predicting Molecular Traits from Tissue Morphology Through Self-interactive Multi-instance Learning
Hu Y. et al, (2022), Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), 13432 LNCS, 130 - 139
RFID analysis of the complexity of cellular pathology workflow-An opportunity for digital pathology.
Browning L. et al, (2022), Front Med (Lausanne), 9
Digital Pathology Transformation in a Supraregional Germ Cell Tumour Network.
Colling R. et al, (2021), Diagnostics (Basel), 11
Understanding the ethical and legal considerations of Digital Pathology.
Coulter C. et al, (2021), J Pathol Clin Res
Validation of grading of non-invasive urothelial carcinoma by digital pathology for routine diagnosis.
Colling R. et al, (2021), BMC Cancer, 21
WHO/ISUP grading of clear cell renal cell carcinoma and papillary renal cell carcinoma; validation of grading on the digital pathology platform and perspectives on reproducibility of grade.
Browning L. et al, (2021), Diagn Pathol, 16
TET2 Drives 5hmc Marking of GATA6 and Epigenetically Defines Pancreatic Ductal Adenocarcinoma Transcriptional Subtypes.
Eyres M. et al, (2021), Gastroenterology, 161, 653 - 668.e16
A Systematic Review of Prostate Cancer Heterogeneity: Understanding the Clonal Ancestry of Multifocal Disease.
Erickson A. et al, (2021), Eur Urol Oncol, 4, 358 - 369
Artificial Intelligence for Advance Requesting of Immunohistochemistry in Diagnostically Uncertain Prostate Biopsies”.
VERRILL C. et al, (2021), Modern Pathology
The Potential of Artificial Intelligence to Detect Lymphovascular Invasion in Testicular Cancer.
Ghosh A. et al, (2021), Cancers (Basel), 13
Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
Chow K. et al, (2021), Eur J Cancer
IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans.
Wellington D. et al, (2021), Eur J Immunol, 51, 742 - 745
Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.
Ranasinha N. et al, (2021), BJUI Compass, 2, 13 - 23